ArticleOncoimmunology2016

Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting.

Mikko Siurala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.